SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-008899
Filing Date
2023-02-27
Accepted
2023-02-27 16:39:32
Documents
12
Period of Report
2023-02-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K brhc10048950_8k.htm   iXBRL 8-K 24854
  Complete submission text file 0001140361-23-008899.txt   164708

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avro-20230223.xsd EX-101.SCH 3862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20230223_lab.xml EX-101.LAB 23290
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20230223_pre.xml EX-101.PRE 16550
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10048950_8k_htm.xml XML 4383
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 23675675
SIC: 2836 Biological Products, (No Diagnostic Substances)